This company has been marked as potentially delisted and may not be actively trading. NASDAQ:JIVE JPMorgan International Value ETF (JIVE) Price, Holdings, & News Add Compare Share Share Stock Analysis Stock AnalysisDividendHoldingsOwnershipShort InterestTrendsBuy This Stock About JPMorgan International Value ETF (NASDAQ:JIVE) 30 days 90 days 365 days Advanced Chart Get JIVE alerts:Sign Up Key Stats Today's Range$73.43▼$73.7650-Day Range N/A52-Week Range$3.50▼$5.35Volume95,641 shsAverage Volume581,068 shsMarket Capitalization$485.17 millionAssets Under Management$564.56 millionDividend Yield1.86%Net Expense Ratio0.55%Aggregate RatingN/A ETF Overview Jive Software, Inc. is engaged in providing software sales and services. The Company's products are sold on a subscription basis, deployable in on-premise, hosted and cloud instances and used for internal or external communities. Its traditional enterprise software product offerings are based on the Jive platform (the Jive Platform), which is a communication and collaboration hub. It sells its Jive Platform across two communities: internally for employees within the enterprise and externally for customers and partners outside the enterprise. It sells its products through a direct sales force, both domestically and internationally. The Jive Platform product offerings are delivered in two configurations, Jive Internal (Jive-n) for employee networks, and Jive External (Jive-x) as a platform for customer and partner communities. The Jive Platform integrates cloud and customer-built applications through published application programing interfaces and software development kits. Read More JPMorgan International Value ETF ExpensesTypeJIVESize and Style ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.55%0.46%0.56%0.54%0.53%Other Expenses0.00%0.49%0.56%0.52%0.56%Total Expense0.55%0.60%0.76%0.73%0.73%Fee Waiver0.00%-0.55%-0.66%-0.50%-0.63%Net Expense0.55%0.48%0.63%0.63%0.60% Receive JIVE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for JPMorgan International Value ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address JIVE ETF News HeadlinesJIVE Jpmorgan International Value ETFDecember 4, 2024 | seekingalpha.comJPMorgan Market Expansion Enhanced Equity ETFOctober 14, 2024 | 247wallst.comBiotech Alert: With news on MPox, RSV, and more, this tiny firm could disrupt a $3B marketA small biotech is stepping into the spotlight with a first-in-class antiviral platform—and it could be one of the market’s most overlooked opportunities today. NanoViricides, Inc. (NYSE: NNVC) is advancing NV-387, a broad-spectrum antiviral now in human trials, with activity against COVID-19, RSV, influenza, measles, and most recently Mpox. With Phase II trials approved in Africa for the deadliest Mpox strain, the timing couldn’t be more critical.August 18 at 2:00 AM | Smallcaps Daily (Ad)JPMorgan Names Travis Spence Global Head of ETFsAugust 15, 2024 | marketwatch.comJPMorgan Developed International Value LJuly 26, 2024 | morningstar.comMJpmorgan Betabuilders Canada Etf Share Price (BBCA.US)July 20, 2024 | lse.co.ukSee More Headlines JIVE ETF - Frequently Asked Questions How were JPMorgan International Value ETF's earnings last quarter? JPMorgan International Value ETF (NASDAQ:JIVE) announced its quarterly earnings results on Tuesday, November, 1st. The software maker reported $0.05 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.02 by $0.03. The firm's revenue was up 1.6% compared to the same quarter last year. Who are JPMorgan International Value ETF's major shareholders? Top institutional shareholders of JPMorgan International Value ETF include RiverFront Investment Group LLC (19.54%), Envestnet Asset Management Inc. (17.20%), Fountainhead AM LLC (7.28%) and Raymond James Financial Inc. (6.74%). View institutional ownership trends. What other stocks do shareholders of JPMorgan International Value ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that JPMorgan International Value ETF investors own include Achillion Pharmaceuticals (ACHN), Icon Energy (ICON), Tesla (TSLA), Golden Minerals (AUMN), Lions Gate Entertainment Corp. USA (LGF), PepsiCo (PEP) and United Airlines (UAL). Fund Details IssuerJPMorgan Fund NameJPMorgan International Value ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:JIVE Inception Date9/13/2023 Fund ManagerThomas Buckingham, Joyce Weng, Ian Butler, Kyle Williams, Michael Barakos Webwww.jivesoftware.com Phone+1-503-2953700Fund Focus Asset ClassEquity BenchmarkN/A CategoryBroad Equity FocusSize and Style Development LevelBlended Development RegionGlobal ex-U.S. Number of Holdings557 Fund Statistics Assets Under Management$564.56 million Average Daily Volume$0.00 Discount/Premium0.19% Administrator, Advisor and Custodian AdministratorJ.P. Morgan Investment Management, Inc. AdvisorJ.P. Morgan Investment Management, Inc. CustodianJPMorgan Chase Bank, N.A. DistributorJPMorgan Distribution Services, Inc. Transfer AgentJ.P. Morgan Chase Bank, N.A. TrusteeN/A Lead Market MakerOld Mission Options OptionableN/A Short Interest6,400 shs Miscellaneous Outstanding Shares6,600,000Beta0.76 Creation Unit50,000 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report Top 10 JIVE HoldingsJPMORGAN PRIME VAR 12/49Holding Weight: 2.23%Roche Holding AGHolding Weight: 1.62%Shell plcHolding Weight: 1.61%HSBC Holdings plcHolding Weight: 1.54%Samsung Electronics Co., Ltd.Holding Weight: 1.42%Allianz SEHolding Weight: 1.14%Mitsubishi UFJ Financial Group, Inc.Holding Weight: 1.13%Alibaba Group Holding LimitedHolding Weight: 1.11%BHP Group LimitedHolding Weight: 0.99%TotalEnergies SEHolding Weight: 0.93%Full Holdings DetailsJIVE Sector ExposureJIVE Industry Exposure This page (NASDAQ:JIVE) was last updated on 8/18/2025 by MarketBeat.com Staff From Our PartnersBiotech Alert: With news on MPox, RSV, and more, this tiny firm could disrupt a $3B marketA small biotech is stepping into the spotlight with a first-in-class antiviral platform—and it could be one of...Smallcaps Daily | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | Sponsored"AI Upgrade" Coming Sept. 1stA new “AI Upgrade” is rolling out on September 1st—and tech leaders are calling it transformational. Softbank’...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding JPMorgan International Value ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share JPMorgan International Value ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.